Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ High Yield Corporate Bond ETF vs UnitedHealth Group Inc — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.53, while UnitedHealth Group Inc trades at $431.99 (market cap $396.27B). The key difference: UnitedHealth Group Inc pays a 2.13% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| HYG | UNH | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $81.32 | $436.35 |
52-Week Low | $78.72 | $237.77 |
Market Cap | — | $396.27B |
Enterprise Value | — | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HYG trades at $79.68 with minimal daily movement, showing a slight gain of 0.04%. Technical indicators are bearish overall, with moving averages signaling sell pressure and oscillators neutral. Recent dividends include H1-26 payments of $0.41 and $0.42, with another $0.37 scheduled for H2-26. Bond ETF inflows are surging, with $300 billion reported by Benzinga on July 20, 2026, as higher yields attract income-seeking investors.
The outlook remains cautious due to bearish technical signals and Fed rate uncertainty. Opportunities exist from strong bond ETF demand, but risks include potential rate hikes and high-yield sector volatility. CNBC reported on June 18, 2026, elevated put volume against HYG, indicating bearish bets. Investors should weigh yield appeal against macroeconomic headwinds.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
